← SynDRA
AMIBEGRON
SynDRA canonical compound SYN0022886 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | ADRB3 |
|---|
| Mechanism of action | adrenergic receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- ADRB3 AGONIST
- Beta-3 adrenergic receptor agonist
- ADRB3 FULL AGONIST
- adrenergic receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP2C9
- CP2D6
- CP3A7
- KSYK
- SYK
Drug classes
- Adrenergic beta-3 Receptor Agonists
- Adrenergic beta-Agonists
Cross-references
Synonyms
- SR-58611
- SR58611
- SR 58611
- Amibegron (USAN/INN)
- Ethyl 2-[[(7S)-7-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy]acetate
- PDQ3ME68U3
- amibegronum
- RefChem:556949
- DTXCID4027361
- Amibegron [USAN:INN]
- UNII-PDQ3ME68U3
- Amibegron [USAN]
- AMIBEGRON [INN]
- AMIBEGRON [WHO-DD]
- GTPL568
- orb1738264
- SCHEMBL2052478
- SCHEMBL29373533
- CHEBI:188723
- RDJQCOBTKKAQAH-FPOVZHCZSA-N
- BDBM50212977
- EX-A11963
- SR-58,611A
- NCGC00371013-01
- NCGC00371013-03
- CS-0041594
- NS00069213
- D08850
- BRD-K24610819-003-01-8
- SR-58611A
- SR58611A
- آمیبگرون
- アミベグロン
- 阿米贝隆
- MS-27908
- DA-78002
- SR 58611A hydrochloride
- SR58611 hydrochloride
Look up AMIBEGRON in the interactive SynDRA portal →